English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
What the DEA Got Wrong About Ayahuasca: Inside a Flawed Federal Report
A 33-page internal document. Two years of foot-dragging before it saw daylight. And conclusions that, frankly, read less like a scientific review and more like a brief written by someone who had already decided how the story ends. That's the short version of the Drug Enforcement Administration's report on ayahuasca — a paper titled Ayahuasca: Risks to Public Health and Safety, dated July 2020, finally pried loose through a Freedom of Information Act request by the Chacruna Institute and the Church of the Eagle and the Condor. If you're a reader who's been quietly considering an ayahuasca retreat, weighing whether plant medicine might help with depression, addiction, or some stuck place in your life, this document matters. Not because it's accurate. Because it shapes the legal and cultural weather around the medicine you're researching. Let's walk through what the report actually says, where it bends the evidence, and what the broader scientific record looks like when you read it without an agenda. Ayahuasca occupies a strange legal space in the United States. The Supreme Court ruled in 2006 that the União do Vegetal — one of the syncretic Brazilian churches that uses the brew as a sacrament — has a constitutional right to do so under religious freedom protections. Santo Daime won similar protections shortly after. But for newer congregations like the Church of the Eagle and the Condor, getting recognition is a grind, and federal documents like this one are quietly cited to justify keeping the brakes on. So when an agency with enforcement power produces a paper that looks scientific — footnotes, citations, clinical language — it carries weight far beyond its actual rigor. That's what makes the contents worth picking apart. Here's where the report gets specific. It cites the American Association of Poison Control Centers, which logged 538 ayahuasca-related emergency calls between 2005 and 2015. Of those, 150 involved ICU or semi-ICU stays. There were 28 intubations, seven respiratory arrests, and four cardiac arrests. A separate request covering 2012 to 2017 turned up 341 ayahuasca-linked cases and 122 involving DMT specifically. Those numbers sound scary in isolation. Read them again with the timeframe attached. We're talking about a decade. Across an entire country. During years when ayahuasca use was expanding rapidly through both religious and underground channels. And — this is the part the DEA buries on the same page — the agency itself acknowledges that 43% of the cases involved ayahuasca taken alongside other substances. Which means there's no clean way to say the medicine caused the harm. For comparison, the same poison control system fields roughly two million calls every year for everything from accidental Tylenol overdoses to kids eating houseplants. The ayahuasca slice is, statistically, a rounding error. None of which is to say risk doesn't exist — it does, and we'll get to it — but the framing matters. The pattern, once you see it, repeats throughout the document. Cite a study. Acknowledge its findings are modest or inconclusive. Then pivot to a hypothetical worst-case scenario and treat it as the takeaway. A few examples: What's striking isn't that the report mentions risks. Risks deserve mention. What's striking is the asymmetry. When the data points toward danger, the language is confident. When it points toward benefit, suddenly the studies are too small, the controls too weak, the population too narrow. Here's the omission that should bother anyone who cares about honest science. The report is dated July 2020. A landmark study had been published the year before: the first placebo-controlled clinical trial of ayahuasca for treatment-resistant depression, run by Dráulio de Araújo's team at the Federal University of Rio Grande do Norte. Twenty-nine participants. Real methodology. Promising results. It's not in the DEA bibliography. Not cited, not addressed, not refuted. Just absent. You can draw your own conclusions about why a federal review of ayahuasca's therapeutic potential, written in 2020, would simply leave out the most rigorous clinical trial on the subject. The broader academic literature tells a different story than the one the DEA constructs. Recent reviews — including a thorough survey by Brazilian researchers Maia, Daldegan-Bueno, Wießner, de Araújo, and Tófoli in European Neuropsychopharmacology — conclude that the strongest evidence for ayahuasca's therapeutic effects lies in two areas: depression and substance use disorders. Which, if you're researching plant medicine because you're struggling with one of those things, is exactly the conversation you're trying to have. A review published in Human Psychopharmacology by James, Keppler, Robertshaw, and Sessa covers much of the same source material as the DEA report — but reads like it was written by people who actually wanted to understand the medicine rather than build a case against it. Their conclusions are worth quoting because they sound like the kind of thing a thoughtful retreat facilitator would tell you: screening matters. Preparation matters. People with personal or family histories of psychosis carry real elevated risk and should probably not drink ayahuasca. But for healthy individuals using the brew in a structured ceremonial context, the data simply does not support the alarmist framing. Incidence of psychosis in ayahuasca drinkers is reported at under 0.1% of consumers. The União do Vegetal alone has roughly 22,000 members who drink ceremonially every two weeks, year after year, with very rare serious adverse events. That's the lived data. Decades of it. Across continents. None of this means ayahuasca is harmless or right for everyone. The honest version is more nuanced: The DEA's report will probably keep circulating in policy circles for years. Documents like that have long half-lives. But you don't have to take its framing at face value. The science is out there, the ceremonial tradition is older than most modern nations, and the safety record — when the medicine is used the way it has been used for centuries — is considerably better than the prohibitionist paper would have you believe. If, after sitting with all of this, you want to take the next step and actually look at structured options, curated ayahuasca retreats can be browsed on our marketplace here. Read carefully, ask the screening questions back, and trust the slow process of choosing well.
Inside the Ayahuasca Ceremony: What Western Seekers Actually Experience
There’s a particular kind of question I get asked over and over by people considering their first ayahuasca retreat. It’s not does it work? — that’s the easy one. It’s what is it actually like? What happens in the body, in the mind, in those long hours between the first sip and sunrise? And does the experience of a Western traveller in the upper Amazon look anything like the textbook descriptions of plant medicine and master plants we read about online? A few years back, a group of researchers sat down with nine foreign participants at a retreat centre in Peru and asked them, in the gentlest possible way, to describe what they’d just gone through. No leading questions. No checklists. Just: tell me about your ceremony. The patterns that emerged are some of the most useful reading I can recommend to anyone weighing a booking decision — not because they tell you what will happen to you, but because they sketch the shape of what tends to happen across very different people in the same ritual container. Here’s what stood out, and why it matters if you’re considering ayahuasca for addiction, depression, trauma, or one of those stuck life patterns nothing else seems to touch. The setup was straightforward. Nine Western participants attended six ceremonies over the course of a traditional retreat in the Peruvian Amazon. The morning after the second ceremony — close enough that memory was vivid, far enough that they’d slept on it — researchers conducted open narrative interviews. People were invited to talk freely, and the transcripts were combed for recurring themes using qualitative content analysis. What’s nice about this approach is that it doesn’t force the experience into a pre-shaped box. Quantitative studies on psychedelics are useful — we need them — but they tend to flatten the texture of what people actually live through. Numbers can tell you that depression scores dropped at week five. They can’t tell you about the hour you spent crying about your father, or the strange certainty that a forest of geometric vines was teaching you something about your marriage. Three big buckets emerged from the interviews: what happened during the ceremony itself, how participants made sense of the process afterwards, and how prepared (or unprepared) they felt going in. Inside the first bucket, the researchers found a familiar list — physical symptoms, visions, received messages, emotional reactions, cognitive shifts, and the meaning people attached to all of it. One of the things that surprises new drinkers most is how physical ayahuasca is. About an eighth of everything participants talked about in the study was somatic — body sensations, temperature shifts, tingling, pressure, nausea, the famous purge. This isn’t a footnote to the psychedelic experience; for many people, it is the experience. Veterans of the ceremony often describe the onset as something foreign moving in — an energy, a presence, a current that takes up residence in the nervous system. That language sounds woo-woo on the page, but it’s remarkably consistent across cultures and decades of reporting. And brain imaging gives us a partial explanation: ayahuasca lights up regions like the anterior insula and paralimbic cortex, areas tied to interoception (your sense of what’s happening inside your body) and emotional processing. Disruption in these same regions has been linked to depression, addiction, PTSD, and complex trauma. So when the medicine cranks up your felt sense of your own body, it’s plausibly working on the exact circuitry that trauma has muted. And then there’s the purge. Vomiting, sometimes diarrhoea, occasionally both — what curanderos call la purga. The harmala alkaloids in the brew interact with stomach enzymes, and the DMT acts on serotonin receptors in your gut. The chemistry is real. But in the tradition, this isn’t a side effect to be managed; it’s the medicine doing its job. Participants in the study, and in pretty much every ayahuasca account I’ve read, describe the purge as something that releases — old grief, old anger, a knot they didn’t know they’d been carrying since they were nine. Some Amazonian lineages call it getting well. After enough ceremonies, you start to understand why. Every single person in the study reported significant emotional release. Not a polite tear or two — actual catharsis. Researchers sorted these into three rough categories: pleasant, unpleasant, and what they called hedonistic. The most interesting pattern was the sequence. Unpleasant emotional states tended to be followed by pleasant ones, as if the medicine were walking people through a difficult room and then opening a window on the other side. This matches something therapists have known for a long time: avoidance keeps pain alive, and contact with it — under the right conditions — is what allows it to move. Ayahuasca seems to dismantle the psychological defences people normally lean on, which is both why it can feel terrifying and why it can be so useful. You can’t intellectualise your way out of what the vine is showing you. You have to feel it. Research with psilocybin has found that what predicts long-term improvement isn’t whether the trip was pleasant — it’s whether the difficult parts got worked through. There’s a concept called emotional breakthrough that closely echoes the old psychoanalytic idea of catharsis: a hard experience, met fully, that resolves into something. Ayahuasca seems to produce these breakthroughs reliably, which is one reason it shows up in conversations about addiction recovery and trauma healing alongside ibogaine and psilocybin-assisted therapy. Participants also described things that sound almost gentle by comparison — heightened self-love, more empathy, the strange experience of meeting themselves with kindness for the first time in years. There’s growing evidence that ayahuasca drinkers score higher on measures of self-acceptance and present-moment awareness, the kinds of qualities that mindfulness-based therapies spend months trying to cultivate. Three of the nine participants reported direct communication with what they described as entities or presences — supportive figures, sometimes recognisable, sometimes not. This is one of the more delicate parts of any honest conversation about ayahuasca. If you’ve never had the experience, it sounds either embarrassing or alarming. If you’ve had it, you know that explaining it to someone who hasn’t is a fool’s errand. What the research is careful about — and what I think any prospective retreat-goer should be careful about too — is the question of what to do with these encounters. Are they projections of the unconscious? Genuine non-human intelligences? Something the Western frame doesn’t have a word for? You don’t need to settle that question to benefit from the experience. What matters, practically, is that the messages tend to feel meaningful to the person receiving them, and that they often connect to whatever the person came into ceremony carrying. Visions, similarly, ranged from the abstract — geometric patterns, lattices of light — to the deeply personal, like watching scenes from one’s own childhood replay with new context. The participants didn’t describe these as entertainment. They described them as instruction. A few honest takeaways from sitting with this material — and from sitting in ceremonies myself. If you’re shopping retreats, the things to look for are surprisingly mundane. Medical screening. A clear policy on antidepressants and other medications. Facilitators who can name their lineage and their teachers without getting cagey. A sensible participant-to-shaman ratio. Aftercare, or at least a real handoff to integration support. Honest cost transparency — and yes, a real ceremony with experienced practitioners is rarely cheap, but exorbitant prices aren’t a quality signal either. Red flags? Anyone promising specific outcomes. Anyone discouraging you from talking to your doctor. Anyone running ceremonies so large that the shaman can’t actually see what’s happening to each person. Anyone framing the medicine as a one-shot fix rather than the start of work you’ll continue on your own. For readers ready to take this further, a range of vetted ayahuasca retreats and other plant-medicine programmes can be browsed on our marketplace here. Sit with the decision; the right time tends to make itself known.
How Ayahuasca Reshapes Personality: A Look at Traditional Healing
Ask anyone who has sat through a full ayahuasca ceremony what changed afterward, and you’ll rarely get a clean answer. They’ll talk about feeling lighter. About no longer being able to lie to themselves the way they used to. About catching themselves mid-reaction and choosing differently. The language is fuzzy, but the underlying claim is bold: ayahuasca changes who you are. That claim has bumped into clinical research over the past decade, and the picture forming is genuinely interesting. Not the breathless "rewire your brain in one night" version. Something more grounded — measurable shifts in personality structure, observed weeks and months after ceremony, in participants working within traditional Amazonian frameworks. Let’s unpack what that actually means, because if you’re considering a retreat, this is the kind of thing worth understanding before you book anything. When researchers talk about personality, they don’t mean your sense of humor or whether you’re an introvert at parties. They mean stable patterns — the deep grooves that shape how you react to stress, how open you are to new ideas, how disciplined you are about long-term goals. The standard model used in psychology breaks this into five traits: openness, conscientiousness, extraversion, agreeableness, and neuroticism. These are supposed to be fairly fixed by adulthood. Hard to budge. That’s why the ayahuasca research is raising eyebrows. Studies looking at people who have participated in ceremonies — particularly within traditional or syncretic contexts like Santo Daime and the UDV — keep finding the same pattern. Openness goes up. Neuroticism goes down. Self-transcendence, which gets at how connected someone feels to something larger than themselves, increases. And these changes don’t fade after a week. Follow-ups months later show the shifts holding. I want to be careful here. The samples are often small, the participants are self-selected, and most of these studies measure people who already chose to engage with the medicine — not skeptics dragged in for science. Still, the consistency of the findings is hard to ignore. Here’s something the clinical literature is starting to catch up to: set and setting aren’t soft variables. The container the medicine is held in seems to shape the outcome as much as the brew itself. Drinking ayahuasca alone in a hotel room is not the same experience as drinking it in a maloca with a curandero singing icaros, a circle of fellow participants, and a dieta you’ve been holding for two weeks. Traditional Amazonian practice frames the medicine inside a whole worldview. There are master plants — teachers in their own right, plants you study with through extended retreats and restricted diets. There’s the idea that the medicine shows you what needs attention, but you’re responsible for what you do with what you see. There are protocols around food, sex, salt, sugar, and emotional environment that participants follow for weeks before and after. The whole thing assumes you’re not just taking a substance. You’re entering a relationship. Participants who sit within this kind of structure report different outcomes than those who do not. They describe the personality shifts as feeling earned, integrated, grounded in something specific — not as if a chemical just rearranged their wiring overnight. The framework gives the experience somewhere to land. Abstract trait changes are one thing. What does it look like when someone’s personality structure actually loosens up after working with ayahuasca? A few patterns show up over and over in participant accounts: None of this is guaranteed. I’ve also met people who sat through a dozen ceremonies and still struggle with the same things they walked in with. The medicine isn’t a magic wand. But the pattern of reported change, especially around addiction recovery and rigid self-defeating patterns, is consistent enough that it’s now a serious area of clinical investigation. Neuroscience has a partial answer. Ayahuasca contains DMT, which binds to serotonin receptors implicated in mood and cognitive flexibility. There’s evidence the brew temporarily relaxes the default mode network — the part of the brain most associated with the constant background hum of self-referential thinking. When that network quiets, the rigid loops of "who I am" and "what I’ve always done" can briefly come unstuck. But neuroscience only gets you so far. People who’ve sat in ceremony will tell you something happens that isn’t reducible to receptor activity. There’s a sense of being shown things. Of being met. Of being worked on. Whether you frame that as the unconscious surfacing in vivid form, or as the medicine itself doing the teaching the traditions claim it does, the experiential reality for participants is rarely "I took a drug and felt funny." It tends to be closer to "I was confronted with something I needed to see." That confrontation, sustained across multiple ceremonies and held inside a serious framework, seems to be where personality change actually happens. Not in the trip itself but in what you do with what you saw afterward. If any of this is landing for you — if the reason you’re reading is because something inside you is stuck and you’re wondering whether plant medicine might help — a few honest pointers from someone who’s spent years around this world: The conversation about psychedelics and addiction recovery, about plant medicine for trauma and stuck patterns, is no longer fringe. Clinical trials are running, indigenous communities are speaking up about how their medicines should be carried into the wider world, and people are finding things in ceremony that decades of talk therapy didn’t reach. None of that means a retreat is the right call for you specifically. It just means the question is worth taking seriously. If something in this article has nudged you closer to that question, a range of carefully curated ayahuasca retreats — including ones rooted in traditional Amazonian frameworks — can be browsed on our marketplace here. Take your time with the decision. The medicine, if you ever sit with it, will ask you to have done exactly that.
The Ayahuasca Diet Explained: What to Eat and Avoid Before Ceremony
If you've started reading about ayahuasca retreats, you've probably bumped into the word dieta — and the slightly intimidating list of foods you're supposed to drop in the weeks before ceremony. No aged cheese. No fermented things. No pork. No chocolate. (Yes, really, no chocolate.) For a lot of people, that's the first moment the whole thing stops feeling abstract and starts feeling real. You're actually doing this. So let's talk about what the ayahuasca diet actually is, why it exists, and how to follow it without turning your kitchen into a misery zone for a month. This is the same territory anyone serious about plant medicine and master plants ends up walking — whether the goal is addiction recovery, working through depression, or just finally looking honestly at the patterns that have been running the show for too long. The dieta is two things at once, and people often confuse them. The first is a hard-edged medical safety protocol — there are foods and substances that can react badly with the brew, and you genuinely need to avoid them. The second is a softer, older idea from Amazonian tradition: that preparing your body, quieting your habits, and stepping back from stimulation makes you more available to whatever the medicine has to show you. Both layers matter. The medical one keeps you safe. The traditional one shapes the quality of the experience. Skip the first and you risk an unpleasant or dangerous reaction. Skip the second and you're more likely to spend the ceremony processing last week's burrito instead of the things you actually came to look at. Most reputable retreats will hand you a written list of restrictions and a timeline — usually somewhere between two and four weeks before your first ceremony, and continuing for a stretch afterward. The exact length varies. Some traditions are stricter than others. If your retreat hasn't given you a clear list, that's worth a polite question before you arrive. Here's the part that actually matters for safety. Ayahuasca contains MAO inhibitors — specifically, the harmala alkaloids from the Banisteriopsis caapi vine. MAO inhibitors block an enzyme in your body called monoamine oxidase, which normally breaks down certain compounds, including tyramine. Tyramine is a naturally occurring amino acid that shows up in aged, fermented, smoked, and cured foods. Under normal circumstances your body handles it fine. But when MAO is inhibited and you load up on tyramine-rich foods, blood pressure can spike sharply. The medical term is a hypertensive crisis. The practical translation: pounding headache, nausea, and in rare serious cases, something that needs a hospital. This isn't shamanic superstition — it's the same reason people on prescription MAOI antidepressants are handed a similar food list. The other layer is serotonergic. Ayahuasca is powerfully serotonergic, and combining it with other serotonergic drugs (SSRIs, SNRIs, MDMA, certain migraine meds, St John's Wort, tramadol, and more) can trigger serotonin syndrome. That's not a food issue, it's a medication issue — and it's the single most important conversation to have with the retreat's medical screener before you book anything. Don't lie on that form. Don't quietly stop your antidepressants a week before. Talk to a doctor who knows what tapering safely actually looks like. Different lineages and different retreats vary in how strict they are, but the core list is fairly consistent. Here's what almost everyone agrees on: Salt and spice get reduced, not necessarily eliminated. The goal isn't a punishment fast; it's a clean, simple intake that doesn't demand much from your digestion. This part gets lost in the lists of forbidden things. The dieta isn't about deprivation. It's about eating cleanly and simply for a few weeks. Most people land somewhere close to a plant-forward, mildly seasoned, home-cooked rhythm. Good things to lean into: fresh fruit (eaten ripe but not overripe), most vegetables, rice, quinoa, oats, lentils, beans, plain potatoes and sweet potatoes, fresh fish in moderation if your retreat allows it, nuts and seeds in small amounts, herbal teas (chamomile, peppermint, ginger), and plenty of water. Olive oil is fine. Fresh herbs are fine. A little garlic and onion, fine. People often report feeling unexpectedly good a week or two into the diet — clearer mornings, steadier moods, better sleep. That's not the medicine yet. That's just what happens when you stop pouring sugar, caffeine, and alcohol on a nervous system. Take notes. That baseline is useful information. The honest truth: the first week is the hardest. Caffeine withdrawal is real. Social situations get awkward. You'll get invited to a friend's birthday and have to explain why you're drinking soda water. A few things that help: If you slip — a coffee, a glass of wine ten days out — don't spiral. Tell your facilitator honestly when you arrive. They've heard it all. What matters is the last week, and especially the final 72 hours, when the rules tighten and the safety stakes go up. Here's something the food lists don't capture. The diet isn't really about food. It's about practice — about training the part of you that can say no to an impulse for a few weeks, that can simplify, that can pay attention. People who treat the dieta as a chore tend to have a harder ceremony. People who treat it as the first stage of the work tend to walk in already partway home. That's true whether your reason for sitting is addiction recovery, trauma, depression, grief, or just the sense that something in your life has gone quietly stuck. The reduction in stimulation makes room. The simplicity of the meals tunes you down to a frequency the medicine can meet. By the time you're sitting in the maloca on night one, you've already been preparing for weeks, and your body knows it. This is also why the diet continues afterward — usually for at least a few days, sometimes longer. Integration is fragile. Your nervous system is open. A heavy meal, a few drinks, a big argument in the first 48 hours can scramble what's still settling. Treat the post-ceremony window with the same care as the lead-up. If reading this list of restrictions makes you feel something like dread or resentment, that's worth sitting with. The dieta is a small ask compared to what the ceremony itself will ask of you. If a month without coffee and chocolate already feels impossible, it's worth asking yourself what that signal is telling you — and whether now is actually the right time, or whether some groundwork (therapy, a clearer reason for going, a conversation with someone who's done it) might come first. And if it doesn't feel like dread — if it feels more like quiet relief that someone is finally telling you to slow down and eat simply for a few weeks — that's a good sign too. For readers who want to take this further, a range of vetted ayahuasca retreats and ceremonies can be browsed on our marketplace here. Whatever you choose, do the diet honestly. The medicine notices.
Is the Ayahuasca Vine Running Out? The Conservation Story Nobody at Retreats Talks About
If you've spent any time researching ayahuasca retreats, you've probably read the brochures. The reverence for the vine. The lineage of the curanderos. The candlelit maloca three hours into the night. What you've almost certainly not read — and what almost no retreat website wants to bring up — is whether the plant at the center of all this is being harvested faster than the rainforest can grow it. I want to talk about that. Because if you're seriously considering booking an ayahuasca ceremony, you're stepping into a story that's bigger than your own healing. The vine has its own life, its own ecology, and increasingly, its own crisis. None of this should scare you off a retreat. But it should change how you choose one. Ayahuasca is a brew. Usually two plants, sometimes more. The psychoactive punch comes from DMT-containing leaves — most commonly chacruna (Psychotria viridis) or, in parts of Brazil, chaliponga. But the leaves on their own do nothing when you drink them. Your gut breaks the DMT down before it can reach your brain. That's where the vine comes in. Banisteriopsis caapi — caapi, jagube, mariri, depending on where you are — contains harmala alkaloids that switch off the enzyme responsible for that breakdown. Without the vine, no journey. The Quechua word ayahuasca means “vine of the soul,” and it refers both to the plant and to the brew. Among most Amazonian traditions, the vine is considered the elder, the teacher, the actual master plant. The leaves are the voice; the vine is the spirit doing the talking. This matters for conservation because the vine is the slow-growing one. Chacruna grows back like a weed. Caapi takes years — sometimes a decade or more — to reach the maturity that traditional brewers consider proper. You can't simply replant your way out of a shortage in a single season. Western botany has been calling caapi a single species since Richard Spruce described it in 1852. But the people who actually use the plant have always known better. Ayahuasqueros across the Amazon distinguish numerous varieties — tucunacá, caupuri, cielo, trueno, ourinhos, and many more — each with its own appearance, character, and felt effect in ceremony. For a long time, scientists shrugged. Even the legendary ethnobotanist Richard Evans Schultes admitted he couldn't visually tell the varieties apart, even though indigenous brewers could identify them from across a clearing. More recent Brazilian research has started to confirm what traditional knowledge has held all along: the varieties differ in leaf color, gland arrangement, stem nodes, bark, and crucially, in their alkaloid profiles. A 2020 chemistry study found significant variation in harmala content between varieties — which is a polite scientific way of saying yes, they hit different. Why does this matter to a person booking a retreat? Because conservation isn't just about saving the vine. It's about saving the varieties. If commercial harvesting flattens the genetic diversity down to whichever vines are easiest to find and chop, something irreplaceable is lost — not just biologically, but ceremonially. The honest answer: it depends where you look, and there isn't enough data. The International Union for Conservation of Nature hasn't formally assessed B. caapi. Peer-reviewed papers on its wild population are thin on the ground. So most of what we know comes from ethnographers, working ayahuasqueros, journalists, and the conservationists trying to sound an alarm. Here's what the picture looks like, region by region: The thread connecting all of this is straightforward. Where the vine is used by local communities at a community scale, it's been managed sustainably for centuries. The problems start when global demand collides with a slow-growing plant. There's also a knock-on effect most retreat-goers never hear about. A 2019 study in Conservation Biology linked the ayahuasca tourism boom to jaguar poaching — researchers interviewing vendors and people in the tourism industry traced demand for jaguar teeth, claws, and other parts back, in part, to spiritual-tourism markets. Sacred plants don't exist in a vacuum. When demand for a ceremony economy explodes, all sorts of unintended currents start flowing through the forest. This isn't an argument that ayahuasca tourism is inherently destructive. It isn't. But it does mean the choices a foreign visitor makes — which retreat, which lineage, which sourcing — ripple outward in ways the marketing copy will never describe. I'm not going to tell you to skip an ayahuasca retreat over conservation concerns. The medicine has helped a lot of people who had run out of other options — people working through addiction, depression, trauma loops that wouldn't quit. That's a real thing, and I won't pretend otherwise. But if you're going to drink the vine, you owe it a little curiosity about where it came from. A retreat center that genuinely cares about sustainability will be able to answer questions. The places that get squirrelly when you ask are telling you something. Here are the questions worth asking before you book: A retreat that grows its own vine, works with a known curandero lineage, and can talk plainly about its sourcing is doing more for your safety and your experience than one with prettier Instagram photos. Sustainability and quality tend to travel together. Sloppy sourcing usually means a sloppy operation. The vine of the soul has been quietly holding up a global movement — addiction recovery work, psychedelic-assisted healing experiments, the slow mainstreaming of plant medicine as a serious tool for people who've exhausted everything else. None of that happens without Banisteriopsis caapi, and none of it continues if the forest gives out. The honest truth is that the people drinking ayahuasca in retreat centers are, collectively, one of the major economic forces shaping what happens to the vine. That's not a guilt trip. It's leverage. The retreats that buyers reward — the ones with serious cultivation programs, transparent sourcing, and real relationships with indigenous stewards — are the ones that will define the next decade of this work. If any of this resonates and you're weighing your options seriously, a curated selection of ayahuasca retreats with vetted sourcing and lineage details can be browsed on our marketplace here. Choose carefully. The vine has been patient with us. The least we can do is return the favor.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Where to Find the Best Ayahuasca Retreats in 2026: A Region-by-Region Guide
Ask ten people who've sat with ayahuasca to describe it, and you'll get ten different answers. Profound. Brutal. Hilarious. Like a decade of therapy compressed into eight hours. Like meeting yourself for the first time. The vocabulary tends to escape people, which is part of why anyone considering an ayahuasca retreat does so much research before booking — there's no clean way to know what you're signing up for until you're in it. What you can research is where to go. The geography of ayahuasca has shifted dramatically over the last decade. What used to be a journey reserved for the Peruvian Amazon is now a global network of ceremony spaces — some traditional, some hybrid, some questionable. This guide walks through the regions worth knowing about in 2026, what makes each one different, and the kinds of questions you should be asking before you hand over a deposit. It's not a vacation. I want to be blunt about that because the word "retreat" carries spa-day baggage that doesn't fit. Yes, many centers have beautiful grounds, good food, and hammocks under palm trees. But the core experience — the ceremony itself — is closer to surgery than to a weekend getaway. The brew tastes terrible. You will probably purge. You may meet the parts of yourself you've spent years avoiding. That's the point. People come to ayahuasca for different reasons. Some are wrestling with addiction, depression, PTSD, or grief that won't shift. Others are not in crisis at all — they're curious about consciousness, or feel stuck, or want to understand a tradition they've read about for years. Both are legitimate. The plant doesn't really care about your reason. It tends to show you whatever you most need to see, which is rarely what you came expecting. A good retreat acknowledges all of this upfront. A great one screens you for medical and psychiatric contraindications before you even pay, prepares you with a proper dieta, and — crucially — gives you tools to integrate afterward. Skip the integration piece and you risk turning a powerful experience into an expensive blur. If authenticity matters to you, this is the region to look at first. The Amazon basin is where ayahuasca originated, where the lineages are still intact, and where the maestros and curanderas you've read about actually live and work. The trade-off is logistical: longer flights, more remote locations, and a level of rusticity that some people love and others find rough. Peru is the spiritual home of ayahuasca. Iquitos, Tarapoto, Pucallpa, and the Sacred Valley near Cusco all host serious centers. The Shipibo lineage — known for their icaros, the medicine songs sung during ceremony — is particularly well represented around the Ucayali river region. Centers run by or in genuine partnership with Shipibo curanderas tend to be the gold standard for traditional practice. What to expect: deeper jungle immersion, longer programs (seven to twelve days is common), and a stricter dieta both before and during the retreat. The food is simple — often plantain, fish, and rice with no salt, sugar, oil, or spice. The accommodations range from rustic tambo huts to comfortable lodges. Costs typically run anywhere from $1,500 to $4,000 for a week-plus stay, which is a fraction of what you'd pay closer to home. Costa Rica has become the entry point for a lot of first-timers who want a credible ceremony space without going deep into the Amazon. The country has stable infrastructure, easier flights from North America, and several well-regarded centers that import Shipibo healers from Peru rather than working with local facilitators. The result is a kind of hybrid: traditional ceremony, more comfortable surroundings, and stronger emphasis on Western-style preparation and integration support. Expect to pay more here — often $3,000 to $5,000 for a week — but the gap is partly justified by the level of psychological screening and aftercare that the better centers provide. If this is your first time and the idea of the deep jungle feels like too much, Costa Rica is a reasonable middle path. Mexico, especially the Yucatán and Riviera Maya, has a growing ceremony scene that blends ayahuasca with other plant medicines like temazcal sweat lodges and bufo. Colombia, particularly around the Sierra Nevada and the Putumayo region, hosts ceremonies led by taita healers from the Cofán and Inga traditions, which use a yagé preparation slightly different from the Peruvian style. Twenty years ago, almost nobody was sitting with ayahuasca in Europe. Today it's one of the fastest-growing regions for ceremony work, driven partly by the cost and hassle of flying to South America and partly by a quietly evolving legal landscape. The plant exists in a gray zone in much of Europe — DMT is controlled, but the brew itself isn't always explicitly named in legislation, and several centers operate under religious-use frameworks. The Dutch psychedelic scene is the most developed in Europe. Amsterdam is famous for legal psilocybin truffle retreats, and ayahuasca ceremonies operate in a tolerated gray area near major cities. Several long-running centers offer ceremonies with facilitators who've apprenticed in Peru, plus structured preparation calls and group integration afterward. If you want a credible ceremony space within a short flight of most European cities, the Netherlands is probably the easiest option. Both countries have decriminalized personal drug use, which has created space for ceremony work to develop more openly than elsewhere in Europe. The Iberian peninsula tends to attract a slower, more contemplative style of retreat — often combined with yoga, vegetarian cooking, and longer integration windows. Centers in Andalucía, the Algarve, and rural Portugal frequently work with visiting Peruvian maestros, blending traditional ceremony with the comforts of a European country estate. Region matters less than the people running the place. I've sat in mediocre ceremonies in legendary jungle lodges and extraordinary ones in unassuming farmhouses. Here's what I'd look at before booking anywhere: A serious retreat will cost you between $1,500 and $6,000 depending on region, length, and amenities. Add flights, travel days, and time off work, and the real number climbs. People sometimes balk at this, then spend the same amount on a beach holiday they'll forget within a year. Whether it's worth it depends entirely on what you're bringing and what you do afterward. I've watched people get a year of insight from one ceremony and waste it within a month by going straight back to old patterns. I've watched others have a relatively mild experience that quietly rewired how they relate to a parent, a partner, or themselves. The plant is one part of the equation. You are the rest of it. If you've read this far, you're already taking the decision seriously, which is the right starting place. Talk to people who've sat with the medicine. Ask hard questions of any center you're considering. Don't book the cheapest option, and don't book the most expensive one just because it looks beautiful on Instagram. For readers who want to start comparing specific ayahuasca retreats across these regions, a curated selection can be browsed on our marketplace here. Whatever you decide, give yourself enough time on the other side to actually absorb what happened. That part matters more than where you went.
The DEA vs. Ayahuasca: How a Flawed Federal Report Tried to Reshape the Conversation
Somewhere in a federal filing cabinet sat a document the public wasn't supposed to see for a long time. It took two Freedom of Information Act requests and the better part of two years before the DEA finally handed it over — a report titled Ayahuasca: Risks to Public Health and Safety, dated July 2020. Once it surfaced, the scientific community read it, raised eyebrows, and then sharpened their pens. If you're researching ayahuasca seriously — maybe weighing a retreat in Peru, maybe wondering whether the legal grey zone in the U.S. is shifting — this story matters. It tells you a lot about why ayahuasca occupies the strange position it does in American law, why research has been so slow despite mounting evidence of therapeutic benefit, and why the regulatory landscape isn't likely to shift overnight. Knowing this context changes how you think about plant medicine, about master plants, and about the whole machinery surrounding psychedelics and addiction recovery in the West. The report came out of an internal DEA review and landed firmly on the prohibitionist side of the ledger. Its core claim: ayahuasca poses a meaningful risk to public health and safety. That framing matters because it props up the federal classification of DMT — the active alkaloid in the brew — as a Schedule I substance. Schedule I, in DEA parlance, means a drug with high abuse potential and no accepted medical use. The agency has long argued that ayahuasca is essentially a delivery vehicle for DMT, which is how it justifies the same legal treatment. The trouble is, the report leaned heavily on a curated stack of references that supported its conclusions while leaving out a striking amount of contrary evidence. There was no mention, for instance, of the first randomized controlled trial of ayahuasca for treatment-resistant depression — a study that suggested both reasonable tolerability and meaningful clinical benefit. There was scant engagement with decades of epidemiological data from Indigenous Amazonian communities and the Brazilian religious churches (Santo Daime, União do Vegetal) where ayahuasca has been consumed ceremonially for generations without the public-health catastrophe the agency seems to anticipate. In other words: the science was selective. Not absent, just trimmed. In June 2023, the Chacruna Institute — together with scholars across biology, neuroscience, psychiatry, anthropology, and sociology — published a formal critique in the Journal of Psychedelic Studies. The article walked through the DEA report point by point, documenting factual omissions, theoretical assumptions presented as established fact, and what looked an awful lot like confirmation bias dressed up in citations. A few of the rebuttal's sharpest threads: The point of the critique wasn't to declare ayahuasca a miracle cure. It was to insist that policy this consequential should rest on a complete reading of the evidence, not a partial one. Here's where the abstract policy fight touches the ground. If you're a person in the U.S. researching ayahuasca because nothing else has worked for your depression, your drinking, your PTSD — the federal stance on plant medicine is a big part of why you're probably looking at a retreat in Peru, Costa Rica, or Brazil rather than a clinic in Colorado. The Schedule I classification creates real downstream effects. Research funding is harder to secure. Clinical trials face procedural hurdles that drugs in other categories don't. Therapists who might otherwise help with integration work risk their licenses if they get too close to the substance itself. And practitioners who run ceremonies in the U.S. — outside the narrow religious exemptions granted to the UDV in 2006 and to Santo Daime shortly after — operate in legal jeopardy. That's the landscape you're navigating when you start comparing retreat centers. The retreat industry that's grown up in Latin America exists in part because of these federal blockages. Many facilitators are themselves U.S. expats who relocated precisely because they couldn't practice openly at home. Short answer: not soon. The agency's mandate is enforcement, not research advocacy. Drug scheduling decisions technically flow from a coordinated process involving the FDA, but the DEA has historically resisted descheduling petitions even when the underlying science had moved on. The most-cited example is cannabis — twenty-five-plus years of state-level legalization, mounting clinical data, and federal scheduling has barely budged. A few realistic paths forward, in rough order of likelihood: For now, the gap between what the research suggests about plant medicine and addiction recovery — and what U.S. policy permits — remains wide. The Chacruna rebuttal won't close it by itself, but it's the kind of scholarship that eventually changes minds in the rooms where these decisions get made. If you've read this far, you're the kind of person who wants to make an informed decision rather than just chase a transformative-sounding weekend. A few honest pointers, born out of the policy reality above: The DEA's report tried to flatten a complex picture into a single warning label. The peer-reviewed response did the harder work of holding multiple truths at once: yes, there are risks; yes, there is therapeutic promise; yes, the science deserves better than selective citation. That's the spirit you want to bring to your own research, too. If something in this piece resonates and you're ready to look at the practical side of things, a curated selection of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision — the medicine isn't going anywhere, and the right setting matters more than the calendar does.
Why Executives and Creatives Are Sitting in Ayahuasca Ceremonies
A few years ago, if you mentioned ayahuasca at a founder dinner in San Francisco or London, you'd get a nervous laugh and a subject change. Now? Somebody at the table has already been. Maybe two people. The conversation has shifted from “you did what?” to “who did you sit with, and would you recommend them?” Plant medicine has crossed a line in the professional world. Not into the mainstream, exactly — your accountant probably isn't booking a dieta in the Sacred Valley — but into a quieter, more curious middle ground. Senior people in tech, finance, design, and the creative industries are showing up at ayahuasca retreats and psilocybin retreats with a specific set of questions: am I burned out beyond repair? Why do I keep building the same problem? What am I avoiding? And, sometimes, the more practical: can this help me think again? This piece is for the reader who's noticed the trend and is wondering whether there's anything real underneath it — or whether it's just the next thing the productivity crowd is using to bypass their own feelings. The cliché answer is creativity. People say they want their edge back, they want to think laterally again, they want to break out of the spreadsheet brain that two decades of decision-making has welded into place. That's part of it. But spend any time with people who've actually done the work and you hear a different story underneath. What most of them are really chasing is relief. Relief from the low-grade depression that high performers learn to hide. Relief from the relationship patterns they keep re-enacting. Relief from a drinking habit that started as networking and turned into a problem. Relief from the dread of getting on another flight, another stage, another all-hands. Creativity is the socially acceptable wrapper. Healing is what's inside. And then there's the addiction question, which is where things get genuinely interesting. A growing number of professionals — and I mean the kind who run companies, not the kind who star in recovery memoirs — are looking at ayahuasca and ibogaine for issues with alcohol, cocaine, prescription benzos, and the more contemporary plague of compulsive screen and stimulant use. Plant medicine for addiction isn't a new idea in the Amazon. It's just newly visible to people who used to think recovery happened in church basements. The science is real, but it's also younger than the headlines suggest. Here's the honest version. What the research does not say: that any of this is a cure, that one ceremony will fix anything permanently, or that it's safe for everyone. Plenty of people have profound experiences and then slowly slide back into the same life they had before. The window closes. Whether anything changes long-term depends almost entirely on what happens in the months after. If you only know plant medicine through the Silicon Valley framing, it's worth pausing on what the traditions themselves call this work. In the upper Amazon, the brew is one of a wider family of master plants — tobacco (mapacho), bobinsana, ajo sacha, chuchuhuasi, chiric sanango, and others — each understood to teach something specific. Curanderos don't talk about neuroplasticity. They talk about cleaning, about diet, about the plants showing you what you need to see. You don't have to buy the cosmology to take it seriously. The point is that ayahuasca didn't arrive in the world as a productivity hack. It arrived as a discipline, with rules, with preparation, with sacrifices. The professionals I've seen get the most from ceremony are the ones who can hold both frames at once — the neuroscience and the older language — without collapsing one into the other. The ones who get the least, in my experience, treat the medicine like a software update. They show up, dose, expect output. The medicine, as the saying goes, has other ideas. If you're weighing whether to book an ayahuasca retreat, here's roughly what to expect from a serious one. (A non-serious one is something different and we'll get to that.) Costs vary widely. A reputable week-long ayahuasca retreat in Peru or Costa Rica generally runs somewhere between $1,500 and $4,500, depending on facilities, lineage of the curanderos, and group size. Cheaper than that, ask hard questions. More expensive than that, ask different hard questions. I'd be doing you a disservice to write a piece like this without naming what can go wrong. Psychiatric risk is real. People with personal or family histories of psychosis, schizophrenia, or bipolar I should not be doing this work, full stop. Ayahuasca can also surface unprocessed trauma in a way that's overwhelming if there's no integration support. Some retreats are excellent at holding that. Some are not. Medication interactions are real. Ayahuasca contains MAO inhibitors, which can interact dangerously with SSRIs, SNRIs, stimulants, and a long list of other substances. A proper retreat requires a medication washout period under medical supervision. A sketchy one waves it off. Facilitator quality varies enormously. The plant medicine space has its share of self-appointed shamans, charismatic frauds, and outright predators. Sexual abuse in ceremony settings has been documented and is more common than the industry likes to admit. Vet thoroughly. Ask for references from past participants. Look for transparent lineage and long-running operations rather than someone who learned to pour medicine on a six-month course. And then there's the most underrated risk: the post-retreat crash. You come home glowing, convinced everything is different, and then the inbox is still the inbox, the marriage is still the marriage, and three months later you can't quite remember what you saw. Without integration, the insights evaporate. Plan for that part before you book. The honest answer is: sometimes, and not the way you'd expect. People come back with fewer breakthrough product ideas than they expected and more clarity about which projects they should never have started. They get less of a creative high and more of a willingness to have the conversation they've been avoiding. They report finishing things they'd been stuck on for years, less because they had a stroke of genius and more because they finally stopped flinching from the work. The founders I've spoken to who got real value from ceremony almost all say the same thing: it didn't make them better at their job. It made them a different person, and that person did the job differently. Sometimes that person quit the job entirely. Sometimes they stayed and finally led the team like a human being. Either way, it's not really a productivity tool. It's a mirror. If you're considering this for yourself, take your time. Read more than one perspective. Talk to people who've sat in ceremony with the facilitators you're considering. Treat your preparation as seriously as you'd treat any other significant decision in your life — because that's what it is. For readers who want to take this further, a curated range of ayahuasca and plant medicine retreats can be browsed on our marketplace here. The trend isn't really about executives chasing the next biohack. It's about a generation of people who built impressive lives and then quietly realised that none of it touched the thing underneath. The medicine doesn't promise to fix that. It just, occasionally, helps you finally look at it.
The Ayahuasca Vine Explained: Banisteriopsis Caapi, Effects, and What Science Knows
Most people who book an ayahuasca retreat have only a fuzzy idea of what's actually in the cup. They know the word. They've heard the stories — the visions, the purge, the long night in the maloca. What they often don't know is that the brew is a partnership between two plants, and one of them — the vine itself — is doing quiet, essential work that makes the whole experience possible. That vine is Banisteriopsis caapi, and it deserves a proper introduction. If you're considering an ayahuasca ceremony, understanding the caapi vine isn't optional trivia. It tells you why the brew exists at all, why facilitators handle it with such care, and why the legal status of plant medicine is so tangled depending on where you stand. Let's actually look at the plant. The scientific name is Banisteriopsis caapi. Across the Amazon, it goes by other names too — yagé, caapi, the vine of the soul, sometimes just “the vine.” It belongs to the Malpighiaceae family, a botanical group that emerged in the Amazon basin somewhere around 1.25 million years ago, when plant diversity in the rainforest exploded. So the lineage is old. Genuinely old. Older than our species by an embarrassing margin. Visually, it's a beast. The vine can stretch up to thirty meters through the canopy, twisting around host trees like cabling. It puts out small white or pale-pink flowers, usually in January, and from a distance it's hard to distinguish from a few of its botanical cousins. The part that matters for ceremony is the woody stem — pounded, simmered for hours, sometimes for a full day, often combined with another plant to make the brew people travel thousands of miles to drink. Here's where most introductions skip the interesting bit. The caapi vine, on its own, is not the psychedelic. Drink a strong caapi-only tea and you'll feel something — a heaviness, a kind of dreamy intoxication, some nausea, maybe shadowy monochrome visuals that look like smoke or silhouettes. But you won't have the kaleidoscopic, full-architecture visions that ayahuasca is famous for. Not even close. The active compounds in caapi are a group of harmala alkaloids — primarily harmine, harmaline, and tetrahydroharmine. Concentrations vary wildly between vines, anywhere from a fraction of a percent up to eight or nine percent depending on the strain and growing conditions. What these alkaloids do in the body is the clever part: they're monoamine oxidase inhibitors, or MAOIs. They temporarily switch off an enzyme called monoamine oxidase that your gut and liver use to break down certain compounds. One of the compounds your body usually destroys on contact? DMT. Swallow pure DMT and nothing happens — your gut chews it up before it reaches the brain. But take caapi first, and the doorway stays open. Add a DMT-containing plant like Psychotria viridis (chacruna) to the brew, and suddenly DMT becomes orally active. That's the chemistry behind the visions. The vine isn't the psychedelic. The vine is what makes the psychedelic possible. Early researchers were so taken with harmine they once called it “telepathine,” genuinely believing it was responsible for the shared visions ceremony participants sometimes report. We've since walked that back, but the name tells you something about how strange the first scientific encounters with this plant were. The caapi vine is geographically picky. It grows naturally only in the Amazon basin, mainly across: That's it. No native population in Africa, in Asia, in North America. This is partly why most traditional ayahuasca retreat centers cluster in countries like Peru and Brazil — proximity to the source, proximity to the lineages that have worked with the plant the longest. You can grow caapi in greenhouses elsewhere, and people do, but the cultural and ecological context stays anchored in the rainforest. Interestingly, archaeological evidence suggests the vine was being traded long distances even a thousand years ago. A shamanic pouch found in Bolivia, dated to around 1,000 years old, contained traces of both harmine and DMT. Hair samples from mummies in northern Chile's Atacama Desert — a place caapi cannot grow — also tested positive for harmine. Trade networks were moving this plant across the continent well before anyone in Europe had heard of it. This is where things get genuinely murky, and where I'd urge anyone thinking about plant medicine to slow down and pay attention. The legality of caapi versus the legality of the finished brew are two very different questions. In the United States, the caapi vine itself is legal to possess. Harmine and harmaline aren't scheduled. But the moment you combine caapi with a DMT-containing plant to make ayahuasca, you're in possession of a Schedule I substance under federal law. The notable exception came in 2006, when the Supreme Court ruled that members of the União do Vegetal (UDV) — a Brazilian-rooted religion that uses the brew as a sacrament — were exempt under the Religious Freedom Restoration Act. A similar exemption later extended to certain Santo Daime congregations. For most people, though, the brew remains illegal stateside. In Australia and Canada, harmala alkaloids are controlled substances, but the vine itself sits in an ambiguous legal zone — not explicitly banned, not explicitly permitted, and frequently decided case-by-case in court. In much of the Amazon — Peru, Brazil, Bolivia, Ecuador — the brew is recognized as a legitimate cultural and religious practice and is legal. That's the practical reason retreat tourism flows south. If you're researching where to do this work, legality should be one of your first questions, not your last. A retreat operating in a country where the brew is openly sanctioned is a different proposition from one operating in a legal grey zone where everyone — facilitators included — could face problems if something goes wrong. Nobody knows exactly how long indigenous Amazonian communities have been working with ayahuasca. Estimates range from several hundred to several thousand years. Some researchers trace its emergence to the Tukano region in the Colombian Amazon. Others argue for older origins further south. The truth is the lineage predates written records, and most of what we know comes from oral tradition combined with the occasional archaeological clue. The first written accounts came from Jesuit missionaries who started pushing into the Amazon in the 17th century. Predictably, they described the brew in horrified terms — diabolical, infernal, the work of the devil. Their reports tell us more about the missionaries than about the medicine. Westerners didn't actually start drinking it themselves until the 1800s, when explorers and naturalists in the Amazon began documenting the experience firsthand. What's often glossed over in retreat marketing is the diversity of traditional uses. The Piaroa people of Venezuela, for example, use caapi as a hunger suppressant, a stimulant, and a hunting aid — they say it sharpens vision. Other communities use it primarily for healing, for divination, for communicating with what they describe as the spirits of the forest. The vine is considered a teacher in its own right — a “master plant” with its own intelligence and its own lessons. That framing matters. It's not a recreational substance in those traditions. It's a relationship. Ayahuasca tourism, in the form most Westerners encounter it, is a late-20th-century phenomenon. It's grown rapidly since the 1990s, with ceremonies now happening in Costa Rica, Portugal, Spain, the Netherlands, and increasingly in private, underground settings worldwide. People come for different reasons — depression, trauma, addiction recovery, grief, spiritual curiosity, midlife disorientation. The brew doesn't care about your reasons. It tends to show you what's there. If you've only read marketing copy, you'd be forgiven for thinking ayahuasca is a kind of cosmic vision quest with optional vomiting. The real picture is messier and, frankly, more interesting. The full ceremony experience typically lasts six to eight hours — far longer than smoked DMT, which is closer to fifteen or twenty minutes. The harmala alkaloids from the caapi vine give the journey its dreamlike quality, slowing it down, deepening it, sometimes producing what people describe as the sense of being “held” by something older than themselves. The DMT contributes the visual architecture, the geometric complexity, the sense of meeting presences or entities. Then there's the physical side: nausea, sweating, the famous purge (which is sometimes vomiting, sometimes crying, sometimes both at once, sometimes neither). Body load can be intense. Some people lie down for most of the night. Others sit up wrapped in a blanket, watching the inside of their own mind unfold. Each ceremony is different, even within the same retreat, even within the same person across two nights. For people specifically considering plant medicine for addiction or depression, the emerging research is cautiously promising — studies have observed reductions in substance use and depressive symptoms after ceremony, particularly when combined with serious integration work afterward. But it's not a magic bullet. The people I've spoken with who got the most from their experiences treated the ceremony as the beginning of work, not the end of it. Knowing the plant doesn't tell you whether a retreat is right for you. It does, though, give you a foundation for asking better questions. Where is the caapi sourced? Who prepares the brew, and how? Does the facilitator have a real lineage, or did they take a weekend course? What's the screening process — do they check your medications, your medical history, your mental health background? Anyone who skips that screening is cutting a corner you don't want cut. The vine is ancient and the medicine is powerful. Both deserve respect, and so do you. If after all this you find yourself genuinely curious about where the work might lead, a thoughtfully curated selection of ayahuasca retreats can be browsed on our marketplace here — not as a sales pitch, just as a starting point for the kind of careful comparison this decision actually deserves.
Inside the Ayahuasca Vine: What New Genetics Reveal About Mariri
Walk into a well-tended ayahuasca garden in the Brazilian Amazon and ask the caretaker what's growing on those big wooden trellises. You probably won't hear a single Latin name. You'll hear three or four — tucunacá, caupuri, pajezinho — each with its own personality, its own preferred soil, its own reputation in ceremony. For decades, scientists nodded politely at this folk taxonomy and filed everything under one species: Banisteriopsis caapi. The plant medicine community kept insisting the vines were not all the same. Now a small group of geneticists in the Amazon has started checking, and the early results are interesting enough to reshape how we think about ayahuasca itself. If you're researching an ayahuasca retreat — or just trying to understand what's actually in the cup — this is the kind of background that helps. The vine isn't a single ingredient. It's a family of master plants, and the differences between them may be larger than anyone outside the tradition realized. Ayahuasca, at its simplest, is a brew of two plants cooked together for hours. The chacruna shrub (Psychotria viridis) contributes DMT — the molecule responsible for the visions. The mariri vine contributes beta-carbolines, which switch off an enzyme in your gut called monoamine oxidase. Without that off-switch, DMT taken orally is destroyed before it ever reaches your brain. You'd drink the tea and feel essentially nothing. So the vine isn't a supporting actor. It's the reason the medicine works at all. And here's where it gets interesting: the beta-carbolines themselves are mildly psychoactive. They influence mood, dreaming, and the texture of the experience long after the DMT has burned off. Curanderos have always said the vine carries the wisdom of the brew, that chacruna provides the light but mariri provides the teaching. From a pharmacology standpoint, that framing is more accurate than most outsiders give it credit for. Which raises an obvious question. If there are multiple genetic varieties of mariri, and each produces a slightly different chemical profile, then strictly speaking, no two ayahuasca brews are pharmacologically identical. The ceremony you sit in next month and the one your friend sat in last year may be cousins, not twins. The work came out of the National Institute of Amazon Research, where a graduate student named Thalita Zanquetta Luz set out to test whether short stretches of DNA — what biologists call barcodes — could reliably tell different vine lineages apart. Her advisor was a geneticist who happens to be a member of União do Vegetal, one of Brazil's main ayahuasca churches. The church supplied 120 vine samples from four states across the Amazon basin. The findings, published in Genetic Resources and Crop Evolution, were striking on two fronts. First, the genetic markers cleanly separated the three named ethnovarieties the church had been growing for years. The folk taxonomy held up under DNA. Second — and this is the part that should make any plant nerd lean forward — the researchers identified twelve distinct lineages clustered inside those three big groups. There's more diversity inside the vine than the single-species label has ever suggested. One number stands out. The team reported genetic distances of up to 28% between certain varieties. That's not a small difference. That's a number large enough to raise the question of whether some of these vines should be classified as separate species entirely. The researchers are careful — they say more work is needed before redrawing the family tree — but the door is open. Here's the part that always gets me. None of this is news to traditional users. UDV members have been propagating tucunacá, caupuri, and pajezinho as distinct plants for generations. They cut stakes from the parent vine and root them out — vegetative propagation — which means each daughter vine is a clone of the mother. The lineages stay clean. The names stay meaningful. The knowledge passes down through the people who actually work the gardens. Indigenous and mestizo curanderos across the upper Amazon describe even more varieties — vines that produce gentler journeys, vines that bring stronger purging, vines that feel suited to specific kinds of healing work. A maestro in Peru might name half a dozen tipos of yagé, each with its own character and its own ceremonial role. Outsiders tend to hear this and assume it's poetic. The genetics are starting to suggest it's botany. One of the researchers on the new paper put it well: traditional knowledge and scientific knowledge are independent. Neither needs to certify the other. What's happening here is that two ways of knowing the same plant are confirming each other in real time, and that's a quietly significant moment for how Western science engages with plant medicine. If you're weighing a psychedelic retreat — for depression, for addiction recovery, for working through trauma, or because life has gotten stuck in ways you can't quite name — the news about vine diversity isn't urgent. You don't need to memorize ethnovarieties before you book. But there are a few practical things worth filing away. None of this is meant to scare you off. Plant medicine has helped a remarkable number of people break patterns they couldn't break any other way, and the early clinical research on ayahuasca for treatment-resistant depression is genuinely promising. The point is just that the medicine deserves to be treated as a living biological reality, not a uniform product. Mariri has been used ceremonially for at least a few hundred years and possibly much longer. It has its own genus, its own pharmacology, its own ceremonial vocabulary in dozens of indigenous languages. And yet, until very recently, nobody in a lab had checked whether the varieties traditional users describe were genetically distinct. That's a strange gap. It says something about which knowledge counts as knowledge, and which gets left out of the journals. The same INPA team and collaborators at Brazilian universities are now working on full genome sequences for both mariri and chacruna. The hope is to map the vine's biogeography — to figure out where it originated, how it spread, and where the highest genetic diversity sits today. That kind of work could eventually help locate a center of origin for the master plant, the way researchers have done for cacao and cassava. It might also help protect wild populations as ayahuasca tourism continues to grow and demand for vines keeps climbing. For now, the takeaway is more modest. The plant on the trellis is not what the textbooks said it was. It's more varied, more complicated, and more worthy of attention than the single-species shorthand suggested. The curanderos were right. The geneticists are catching up. If you've read this far, you're probably not casually curious — you're considering something. Maybe a retreat in Peru, maybe somewhere in Brazil, maybe somewhere closer to home where psilocybin or another plant medicine is the focus. The vine research is one small piece of a much larger landscape you'll have to navigate. Preparation matters. Choosing facilitators you trust matters even more. And what you do in the weeks and months after a ceremony — the integration work, the conversations, the slow rewiring — often matters most of all. If something in this has nudged you closer to taking the next step, a range of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Take your time with the choice. The vine has been around for a very long time, and it'll still be there when you're ready.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
